S&P 500   5,143.12 (-1.08%)
DOW   38,092.27 (-0.95%)
QQQ   439.59 (-1.30%)
AAPL   176.06 (+0.58%)
MSFT   421.75 (-1.44%)
META   513.68 (-1.81%)
GOOGL   158.31 (-0.69%)
AMZN   186.61 (-1.29%)
TSLA   171.89 (-1.55%)
NVDA   887.20 (-2.09%)
AMD   163.83 (-3.91%)
NIO   4.14 (-7.17%)
BABA   72.49 (-3.15%)
T   16.41 (-0.06%)
F   12.69 (-2.68%)
MU   123.90 (-2.83%)
GE   154.49 (-1.85%)
CGC   8.00 (-1.84%)
DIS   114.60 (-2.18%)
AMC   2.73 (-2.50%)
PFE   26.10 (-0.91%)
PYPL   65.74 (-0.09%)
XOM   123.47 (+1.38%)
S&P 500   5,143.12 (-1.08%)
DOW   38,092.27 (-0.95%)
QQQ   439.59 (-1.30%)
AAPL   176.06 (+0.58%)
MSFT   421.75 (-1.44%)
META   513.68 (-1.81%)
GOOGL   158.31 (-0.69%)
AMZN   186.61 (-1.29%)
TSLA   171.89 (-1.55%)
NVDA   887.20 (-2.09%)
AMD   163.83 (-3.91%)
NIO   4.14 (-7.17%)
BABA   72.49 (-3.15%)
T   16.41 (-0.06%)
F   12.69 (-2.68%)
MU   123.90 (-2.83%)
GE   154.49 (-1.85%)
CGC   8.00 (-1.84%)
DIS   114.60 (-2.18%)
AMC   2.73 (-2.50%)
PFE   26.10 (-0.91%)
PYPL   65.74 (-0.09%)
XOM   123.47 (+1.38%)
S&P 500   5,143.12 (-1.08%)
DOW   38,092.27 (-0.95%)
QQQ   439.59 (-1.30%)
AAPL   176.06 (+0.58%)
MSFT   421.75 (-1.44%)
META   513.68 (-1.81%)
GOOGL   158.31 (-0.69%)
AMZN   186.61 (-1.29%)
TSLA   171.89 (-1.55%)
NVDA   887.20 (-2.09%)
AMD   163.83 (-3.91%)
NIO   4.14 (-7.17%)
BABA   72.49 (-3.15%)
T   16.41 (-0.06%)
F   12.69 (-2.68%)
MU   123.90 (-2.83%)
GE   154.49 (-1.85%)
CGC   8.00 (-1.84%)
DIS   114.60 (-2.18%)
AMC   2.73 (-2.50%)
PFE   26.10 (-0.91%)
PYPL   65.74 (-0.09%)
XOM   123.47 (+1.38%)
S&P 500   5,143.12 (-1.08%)
DOW   38,092.27 (-0.95%)
QQQ   439.59 (-1.30%)
AAPL   176.06 (+0.58%)
MSFT   421.75 (-1.44%)
META   513.68 (-1.81%)
GOOGL   158.31 (-0.69%)
AMZN   186.61 (-1.29%)
TSLA   171.89 (-1.55%)
NVDA   887.20 (-2.09%)
AMD   163.83 (-3.91%)
NIO   4.14 (-7.17%)
BABA   72.49 (-3.15%)
T   16.41 (-0.06%)
F   12.69 (-2.68%)
MU   123.90 (-2.83%)
GE   154.49 (-1.85%)
CGC   8.00 (-1.84%)
DIS   114.60 (-2.18%)
AMC   2.73 (-2.50%)
PFE   26.10 (-0.91%)
PYPL   65.74 (-0.09%)
XOM   123.47 (+1.38%)
NASDAQ:SGRY

Surgery Partners (SGRY) Stock Price, News & Analysis

$26.37
+0.43 (+1.66%)
(As of 10:39 AM ET)
Today's Range
$25.37
$26.51
50-Day Range
$25.94
$35.07
52-Week Range
$22.05
$45.79
Volume
164,561 shs
Average Volume
884,650 shs
Market Capitalization
$3.34 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$43.63

Surgery Partners MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.88 Rating Score
Upside/​Downside
68.2% Upside
$43.63 Price Target
Short Interest
Bearish
11.33% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.38mentions of Surgery Partners in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$608,352 Sold Last Quarter
Proj. Earnings Growth
35.80%
From $0.81 to $1.10 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.91 out of 5 stars

Medical Sector

1882nd out of 2,784 stocks

General Medical & Surgical Hospitals Industry

13th out of 15 stocks

SGRY stock logo

About Surgery Partners Stock (NASDAQ:SGRY)

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

SGRY Stock Price History

SGRY Stock News Headlines

SHOCKING Altcoin Moves…
Bitcoin's recent price boom has sent select altcoins into an absolute FRENZY! Which is why we've gathered 27 crypto experts to share their top picks and predictions as we rapidly approach the Bitcoin halving event this month…
SHOCKING Altcoin Moves…
Bitcoin's recent price boom has sent select altcoins into an absolute FRENZY! Which is why we've gathered 27 crypto experts to share their top picks and predictions as we rapidly approach the Bitcoin halving event this month…
Surgery Partners initiated with neutral view at Barclays
SGRY Mar 2024 30.000 put
Company News for Feb 27, 2024
Q4 2023 Surgery Partners Inc Earnings Call
Surgery Partners: Q4 Earnings Snapshot
SGRY Apr 2024 50.000 call
See More Headlines
Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/26/2024
Today
4/12/2024
Next Earnings (Estimated)
5/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
General medical & surgical hospitals
Sub-Industry
N/A
Current Symbol
NASDAQ:SGRY
Employees
13,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$43.63
High Stock Price Target
$50.00
Low Stock Price Target
$35.00
Potential Upside/Downside
+68.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.88
Research Coverage
8 Analysts

Profitability

Net Income
$-11,900,000.00
Pretax Margin
4.92%

Debt

Sales & Book Value

Annual Sales
$2.74 billion
Cash Flow
$1.70 per share
Book Value
$23.99 per share

Miscellaneous

Free Float
123,315,000
Market Cap
$3.28 billion
Optionable
Optionable
Beta
2.71
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

SGRY Stock Analysis - Frequently Asked Questions

Should I buy or sell Surgery Partners stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SGRY shares.
View SGRY analyst ratings
or view top-rated stocks.

What is Surgery Partners' stock price target for 2024?

8 brokers have issued 12-month price objectives for Surgery Partners' shares. Their SGRY share price targets range from $35.00 to $50.00. On average, they expect the company's stock price to reach $43.63 in the next year. This suggests a possible upside of 68.2% from the stock's current price.
View analysts price targets for SGRY
or view top-rated stocks among Wall Street analysts.

How have SGRY shares performed in 2024?

Surgery Partners' stock was trading at $31.99 at the beginning of the year. Since then, SGRY shares have decreased by 18.9% and is now trading at $25.94.
View the best growth stocks for 2024 here
.

When is Surgery Partners' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our SGRY earnings forecast
.

How were Surgery Partners' earnings last quarter?

Surgery Partners, Inc. (NASDAQ:SGRY) issued its quarterly earnings results on Monday, February, 26th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.37 by $0.07. The business had revenue of $735.40 million for the quarter, compared to analysts' expectations of $741.93 million. Surgery Partners had a positive trailing twelve-month return on equity of 3.65% and a negative net margin of 0.43%. The company's quarterly revenue was up 4.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.22 earnings per share.

What ETFs hold Surgery Partners' stock?

ETFs with the largest weight of Surgery Partners (NASDAQ:SGRY) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS) and BlackRock Future Innovators ETF (BFTR).iShares U.S. Healthcare Providers ETF (IHF).

What guidance has Surgery Partners issued on next quarter's earnings?

Surgery Partners updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $3.0 billion-, compared to the consensus revenue estimate of $3.0 billion.

What is Eric Evans' approval rating as Surgery Partners' CEO?

7 employees have rated Surgery Partners Chief Executive Officer Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Surgery Partners own?
Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by many different institutional and retail investors. Top institutional shareholders include Los Angeles Capital Management LLC (0.02%). Insiders that own company stock include Andrew T Kaplan, Anthony Taparo, Bradley R Owens, Brent Turner, Danielle Burkhalter, David T Doherty, George Goodwin, Harrison R Bane, Jason Eric Evans, Jennifer Baldock, Laura L Brocklehurst, Laura L Brocklehurst, Marissa Brittenham, Teresa Deluca, Thomas F Cowhey and Wayne S Deveydt.
View institutional ownership trends
.

How do I buy shares of Surgery Partners?

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SGRY) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners